Delivery Order SPE2DB22D2206-SPE2DB26FDQ84
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,060.46 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a small-value pharmaceutical delivery under the company's larger federal contract portfolio. The place of performance is listed as Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 30, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $10,329.51. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by September 2, 2025. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $1,270.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $9,127.32 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 29, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a $7,481.93 delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,962.78 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order and functions as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $4,266.36 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Kerendia 20 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 22, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 20 mg, a pharmaceutical product for the treatment of chronic kidney disease. This delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed price contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,008.41 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Kerendia 10 mg, a medication used in the treatment of chronic kidney disease. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDQ84Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,185.78 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count) on October 16, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for Kerendia, a medication used in the treatment of chronic kidney disease, exemplifies the company's role in providing specialized pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill diverse medical supply needs across multiple therapeutic domains for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 10/16/25 |